|
Medical
Research Library
|
|
ValueCentric
|
Trade directors at branded pharmaceutical manufacturers are challenged by the tendency for retail pharmacy chains to supply their distribution centers through wholesalers. Without accurate and timely sales data, trade directors often nd it difcult to fully understand the impact of their indirect chain customers. Furthermore, this group’s (chains, mass merchandisers and grocers) position as the ...
|
|
|
Beckloff Associates
|
The Office of Orphan Products Development (OOPD) was created within the Office of the Commissioner for two purposes: to evaluate requests for orphan drug designation and act as an internal FDA advocate; and evaluate, award, and monitor the progress of orphan drug grants. Read a brief overview of the regulatory legal history of the Orphan Drug Product Program and a description of the orphan drug ...
|
|
|
APQC
|
"Compliance with Sarbanes-Oxley (SOX) regulations is not optional, and many organizations have had little choice but to invest significant financial resources into non-value-adding process documentation, employee training, IT systems, and external consulting. But aside from passive compliance benefits, these investments have brought little reward.
This excerpt describes how leading organizations ...
|
|
|
Technology Business Research, Inc
|
CSC fell short of its potential. Funding approval delays and lengthened decision cycles in the federal
government wreaked havoc on CSC’s 3Q10 results. Revenue derived from the North American Public Sector
(NPS) was down 4.5% year-to-year, while Business Solutions & Services (BS&S) and Managed Services Sector
(MSS), CSC’s commercial outsourcing businesses, growing at 0.6% and 0.1% year-to-year, ...
|
|
|
|
